RxDoctor Payments Data
★ My doctorsLook up a doctor →

Venika Ford, NP

Hematology & Oncology · Cartersville, GANPI 1356077655

Payments from drug & device makers

$8,927in general payments, 2019–2025

Across 394 payments — averaging $22.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$678
  • Seagen Inc.$649
  • Daiichi Sankyo Inc.$610
  • AstraZeneca$579
  • Johnson & Johnson$542
  • Pfizer$512
  • plus $5K from 48 others

What the payments were for

  • Food & beverage$8,19792%
  • Education$7308%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck27$678
Seagen Inc.23$649
Daiichi Sankyo Inc.26$610
AstraZeneca(2 entities)26$579
Johnson & Johnson17$542
Pfizer31$512
Novartis24$502
Genentech USA, Inc.23$471
Bristol Myers Squibb18$412
Eisai Inc.16$305
E.r. Squibb & Sons, L.L.C.15$289
GSK11$240
AbbVie9$239
Bayer9$219
Jazz Pharmaceuticals Inc.6$199
Gilead9$178
Stemline Therapeutics Inc.7$178
Regeneron Healthcare Solutions, Inc.6$173
Incyte Corporation8$156
Takeda Pharmaceuticals U.S.A., Inc.5$117
Deciphera Pharmaceuticals Inc.5$109
Karyopharm Therapeutics Inc.5$108
Exelixis Inc.5$98
Adaptive Biotechnologies Corporation4$95
Puma Biotechnology, Inc.4$94
Tersera Therapeutics LLC3$85
Beigene USA, Inc.4$81
Sobi, Inc4$75
Amgen4$74
Sanofi2$73
Lilly USA, LLC3$65
Taiho Oncology, Inc.2$59
EMD Serono, Inc.2$48
Rigel Pharmaceuticals, Inc.2$48
Array Biopharma Inc5$44
Syndax Pharmaceuticals, Inc.2$42
ADC Therapeutics America, Inc.2$39
Legend Biotech USA Inc.2$37
Boehringer Ingelheim1$34
Geron Corporation2$33
Blueprint Medicines Corporation1$32
Beone Medicines USA, Inc.2$32
Tempus AI, Inc1$30
Sun Pharmaceutical Industries Inc.1$27
Springworks Therapeutics, Inc.1$27
AVEO Pharmaceuticals, Inc.1$26
Sumitomo Pharma America, Inc.1$24
Coherus Oncology, Inc.1$23
Mirati Therapeutics, Inc.1$22
Organon1$20
G1 Therapeutics, Inc.1$20
Genmab U.S., Inc.1$19
Caris MPI, Inc.1$19
Astellas Pharma US Inc1$16

How this compares

$8,927 in reported general payments places this provider in the 50th percentile of 370 hematology & oncology providers in Georgia.

See all hematology & oncology providers in Georgia →

Medicare billing

Part B allowed, 2024
$34,152
Medicare patients
208
Services billed
477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Cartersville

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →